Novel adjuvanted recombinant HPV 9-valent vaccine (Undisclosed novel adjuvant,Jiangsu Rec-Biotech)

新佐剂重组九价HPV疫苗（未披露的新型佐剂，江苏瑞科生物）

Report date: 2025/12/11 09:45:12

Base Information

Drug NameNovel adjuvanted recombinant HPV 9-valent vaccine (Undisclosed novel adjuvant,Jiangsu Rec-Biotech)
Drug Alias NameREC-604c
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesJiangsu Rec-Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Rec-Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A